Research
Research project in progress

SINERGIA: Innovation, Diffusion and Green Growth

Francois Cohen and Joëlle Noailly
35
Teaching
Academic courses

Gender and Bodies in Global Health

Claire Somerville
3
News
30th March 2021

Covid-19 Vaccine R&D Largely Public Money and Highly-Concentrated, New Data Resource Finds

Global Health Centre
3
News
11th July 2020

The Vaccine Race: Will Public Health Prevail over Geopolitics?

Suerie Moon and Global Health Centre
310
Publications
Blog, 28 December, 2016

Global Health Disruptors: Migration

Michaela Told
317
Events
13 November, 2015

Global Health – Do Think Tanks Matter?

Maison de la paix, Geneva
Miriam Sangiorgio, Michaela Told and Ilona Kickbusch
316
Research
Research project in progress

When Money Can’t Buy Food and Medicine: Banking Challenges in the International Trade of Vital Goods and their Humanitarian Impact in Sanctioned Jurisdictions

Gregoire Mallard
3
Events
25 March, 2021

Non-commercial pharmaceutical R&D: What do PDPs suggest about costs and efficiency?

Global Health Centre and Suerie Moon
316
News
11th May 2020

De Managua au Cap, le trafic de drogue au temps du COVID-19

Dennis Rodgers
3
Events
15 April, 2024

AI, Public Input, and Qualitative Research in Global Health Policy – Research Café with Christopher Colvin

Maison de la Paix
Global Health Centre
3
News
4th October 2019

Team from Weizmann Institute of Science Wins 2019 Geneva Challenge on Global Health

Ilona Kickbusch
3
Events
6 March, 2023

Community-Based Health Insurance in Rwanda: Organization, Payment, and Practice

Maison de la Paix
Global Health Centre
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks